Examine current tools and technologies available to study brain-body connections and how large-scale data collection efforts, ...

The published long-term data suggests that the treatment could maintain its dominant position in the CF market.

Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in ...

Led by early-career researchers, this monthly seminar series features UGOS specific or adjacent work that could benefit both ...

2025 — Insilico Medicine ("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the company will present an oral presentation and ...

Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics.

announced its selection to present at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit on May 13-15, 2025, in Boston, MA. The presentation, titled "Improving Patient ...

About the Symphony IL-6 Test: The Symphony Test platform is designed to determine patient acuity for triage and monitoring based on the measurement of a specific biomarker. The Symphony IL-6 Test ...